- Home
- PROC
PROC
Procaps Group S.A.
as 07-26-2024 4:00pm EST
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
| Founded: | 1976 | Country: | Luxembourg |
| Employees: | N/A | City: | N/A |
| Market Cap: | 283.2M | IPO Year: | N/A |
| Target Price: | $4.50 | AVG Volume (30 days): | 3.2K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.52 | EPS Growth: | -13.33 |
| 52 Week Low/High: | $1.95 - $4.95 | Next Earning Date: | 09-03-2024 |
| Revenue: | $414,096,000 | Revenue Growth: | -4.80% |
| Revenue Growth (this year): | 5.54% | Revenue Growth (next year): | 8.54% |
Latest Procaps Group S.A. News
PROC Breaking Stock News: Dive into PROC Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Procaps Group Announces New Chairman
Business Wire
2 months ago
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F
Business Wire
2 months ago
Procaps Group Delays Filing of Annual Report on Form 20-F
Business Wire
3 months ago
Procaps Group Delays Filing of Annual Report on Form 20-F
Simply Wall St.
3 months ago
Procaps Group S.A. (NASDAQ:PROC) insiders have significant skin in the game with 60% ownership
Business Wire
5 months ago
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
Business Wire
6 months ago
Procaps Issues Shareholder Letter from New CEO
GlobeNewswire
6 months ago
EHang Announces Suggested Retail Price of RMB2.39 Million for EH216-S Passenger-Carrying UAV System in China
Compare PROC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROC Procaps Group S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.